2025 United States Adult And Pediatric Vaccines Market Revenue Opportunities Report
Description
The 2025 United States Adult And Pediatric Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in the United States are Pfizer, Merck & Co., GlaxoSmithKline (GSK), and Sanofi. Pfizer leads with a diverse vaccine portfolio including Prevnar for pediatric use, generating significant revenues and continuing innovation despite COVID-19-related revenue declines. Merck & Co. is a major player known for its Gardasil vaccine targeting HPV, which contributes substantially to its vaccine revenues, although it faces challenges such as the China shipment pause. GSK holds significant market share with its wide range of vaccines, including pediatric immunizations, maintaining its position through innovation and strategic growth. Sanofi is also a key competitor with a strong vaccine presence, particularly via its Sanofi Pasteur division, focusing on both adult and pediatric vaccines in the US.
These companies dominate the US vaccine market, which was valued around $33 billion in 2025 and is expected to grow steadily. They actively expand portfolios through R&D and acquisitions, driving vaccines for infectious diseases across age groups. The market is highly consolidated, with distribution predominantly through retail pharmacies, hospitals, and government suppliers. Vaccine types vary, including recombinant, subunit, and mRNA vaccines, targeting viral and bacterial diseases in both children and adults. Their ongoing innovation and market presence position them as leaders shaping the future of vaccines in the US.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in the United States are Pfizer, Merck & Co., GlaxoSmithKline (GSK), and Sanofi. Pfizer leads with a diverse vaccine portfolio including Prevnar for pediatric use, generating significant revenues and continuing innovation despite COVID-19-related revenue declines. Merck & Co. is a major player known for its Gardasil vaccine targeting HPV, which contributes substantially to its vaccine revenues, although it faces challenges such as the China shipment pause. GSK holds significant market share with its wide range of vaccines, including pediatric immunizations, maintaining its position through innovation and strategic growth. Sanofi is also a key competitor with a strong vaccine presence, particularly via its Sanofi Pasteur division, focusing on both adult and pediatric vaccines in the US.
These companies dominate the US vaccine market, which was valued around $33 billion in 2025 and is expected to grow steadily. They actively expand portfolios through R&D and acquisitions, driving vaccines for infectious diseases across age groups. The market is highly consolidated, with distribution predominantly through retail pharmacies, hospitals, and government suppliers. Vaccine types vary, including recombinant, subunit, and mRNA vaccines, targeting viral and bacterial diseases in both children and adults. Their ongoing innovation and market presence position them as leaders shaping the future of vaccines in the US.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
